Brochure
18 Oct 2024
Daewoong Bio Bioplant Promotion Brochure
PDF 10.0 MB
It contains an overall introduction to Daewoong Bio's bio plant's milestones, manufacturing facilities, and production capacity.
Content provided by our supplier
Daewoong Pharmaceutical Co.,Ltd
-
KR -
2015On CPHI since
-
1000 - 4999Employees
Company types
Primary activities
Other Content from Daewoong Pharmaceutical Co.,Ltd (3)
-
News Daewoong Pharmaceutical Initiates Global Export of 'Novel Drug'...Launches 'Fexuprazan' in the Philippines
‘Fuxuprazan’ is officially launched in the Philippines.convenience of administration ▲low drug interactions and consistency of efficacy. -
Video DAEWOONG PR VIDEO (EN)
We continue to take the initiative by making bold challenges and investments in R&D to leap forward as a global healthcare group. Following the 2022 launch of Fexuclue, a drug treating gastroesophageal reflux disease, the company released Envlo, a Type 2 diabetes treatment. By bolstering its R&D pipeline, Daewoong Pharmaceutical is developing first-in-class and best-in-class drugs.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance